Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vascular Neoplasm”

5,787 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,787 results

Not applicableTemporarily pausedNCT06129760
What this trial is testing

Glioblastoma Remote Monitoring and Care - Research Protocol

Who this might be right for
GlioblastomaVenous ThromboembolismSeizures
Case Comprehensive Cancer Center 25
Not applicableUnknownNCT05414162
What this trial is testing

Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy

Who this might be right for
DLBCLMultiple MyelomaCytokine Release Syndrome+6 more
University Hospital, Bonn 60
Testing effectiveness (Phase 2)Ended earlyNCT01832727
What this trial is testing

Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 65
Not applicableStudy completedNCT04154761
What this trial is testing

Resection of the Inferior Vena Cava Due to Tumor Involvement

Who this might be right for
NeoplasmsSurgery--ComplicationsVascular Diseases+1 more
Hospital Universitario Infanta Cristina 13
Testing effectiveness (Phase 2)Looking for participantsNCT04973605
What this trial is testing

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
BeOne Medicines 246
Early research (Phase 1)Study completedNCT00400556
What this trial is testing

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Who this might be right for
Multiple MyelomaCutaneous Lymphoma
Peter MacCallum Cancer Centre, Australia 6
Not applicableNot Yet RecruitingNCT07398066
What this trial is testing

DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial)

Who this might be right for
NeurosurgeryBrain CancerMeningioma
University of Malaya 60
Early research (Phase 1)Study completedNCT02902237
What this trial is testing

TTF-NGR Phase I Study

Who this might be right for
Malignant Solid TumorsLymphomas
University Hospital Muenster 24
Early research (Phase 1)Study completedNCT00083460
What this trial is testing

Study of Combination PS-341 and Thalidomide in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 86
Large-scale testing (Phase 3)Study completedNCT00392262
What this trial is testing

Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients

Who this might be right for
Hypertension
Novartis 224
Large-scale testing (Phase 3)Active Not RecruitingNCT05083169
What this trial is testing

Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 587
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Not applicableLooking for participantsNCT06697483
What this trial is testing

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Who this might be right for
Multiple Myeloma
Peking University People's Hospital 100
Not applicableStudy completedNCT03115541
What this trial is testing

Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection

Who this might be right for
Venous ThromboembolismThoracic SurgeryEsophageal Cancer
McMaster University 187
Testing effectiveness (Phase 2)Active Not RecruitingNCT03315754
What this trial is testing

Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.

Who this might be right for
Localized Prostate Cancer
Steba Biotech S.A. 50
Not applicableStudy completedNCT02831556
What this trial is testing

Point of Care 3D Ultrasound for Various Applications: A Pilot Study

Who this might be right for
AppendicitisEvidence of CholecystectomyGallstones+20 more
Duke University 174
Testing effectiveness (Phase 2)Ended earlyNCT04465760
What this trial is testing

Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy

Who this might be right for
LymphomaMalignant Solid NeoplasmPlasma Cell Myeloma
OHSU Knight Cancer Institute 9
Large-scale testing (Phase 3)Ended earlyNCT01645124
What this trial is testing

Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV)

Who this might be right for
Polycythemia Vera
Consorzio Mario Negri Sud 365
Not applicableLooking for participantsNCT04648462
What this trial is testing

Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology

Who this might be right for
AstrocytomaEpendymomaGanglioglioma+9 more
Maastricht Radiation Oncology 1,500
Testing effectiveness (Phase 2)Ended earlyNCT03333746
What this trial is testing

Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Yvonne Efebera 1
Load More Results